Vizora日本語

Kohjin BioKohjin Bio Co., Ltd.177A東証グロース医薬品FY ending Mar 2026, consolidated, J-GAAP

Kohjin Bio FY ending Mar 2026 results

About 51% of Kohjin Bio's sales come from Tissue culture business, with Microbiological business and Cell process business making up much of the rest.

Out of every ¥100 of sales, about ¥7 is left as operating profit.

Revenue changed -5.1% from the prior year, operating profit -65.5%.

Revenue and profit pattern

Revenue and profit down

Revenue -5.1% · profit -65.5%, calculated from disclosed figures.

Operating leverage: 12.77× (profit growth ÷ revenue growth)

What changed from last year

FY ending Mar 2025 → FY ending Mar 2026

Revenue
-5.1%¥5.21B → ¥4.94B
Gross profit
-21.5%¥2.37B → ¥1.86B
Operating income
-65.5%¥991.1M → ¥341.5M
Net income attributable to owners
-68.4%¥794.8M → ¥251M
Operating cash flow
-23.7%¥915.6M → ¥698.5M
Free cash flow
-1068.2%¥28.1M → -¥271.6M

Where the money goes

FY ending Mar 2025 → FY ending Mar 2026

Where ¥100 of sales goes

For every ¥100 Kohjin Bio sells, how much goes where, and how much is kept.

FY ending Mar 2026
Cost of sales
¥62
SG&A
¥31
Operating profit
¥7
Net profit kept
¥5

Annual margin trends

Gross margin37.6%
FY ending Mar 2023: 51.7%51.7%FY ending Mar 2024: 39.4%39.4%FY ending Mar 2025: 45.4%45.4%FY ending Mar 2026: 37.6%37.6%FY23FY24FY25FY26
Operating margin6.9%
FY ending Mar 2023: 26.7%26.7%FY ending Mar 2024: 12.5%12.5%FY ending Mar 2025: 19.0%19.0%FY ending Mar 2026: 6.9%6.9%FY23FY24FY25FY26
Net margin5.1%
FY ending Mar 2023: 17.5%17.5%FY ending Mar 2024: 8.1%8.1%FY ending Mar 2025: 15.3%15.3%FY ending Mar 2026: 5.1%5.1%FY23FY24FY25FY26

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2026

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (3)

  • EDINET (FSA Japan)

    有価証券報告書－第45期(2025/04/01－2026/03/31)

    ID S100YB5D2026-06-23Open

  • EDINET (FSA Japan)

    有価証券報告書－第44期(2024/04/01－2025/03/31)

    ID S100W2HI2025-06-24Open

  • EDINET (FSA Japan)

    有価証券報告書－第43期(2023/04/01－2024/03/31)

    ID S100TX402024-06-28Open

Extracted from XBRL: 48 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image